News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Rhythm Pharmaceuticals Announces FDA Review of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
Thursday, August 21, 2025Rhythm Pharmaceuticals Inca commercialstage biopharmaceutical company focused on rare neuroendocrine diseases has reported that the US Food and Drug Administration FDA has accepted for review its supplemental
Jazz Pharmaceuticals Signs Exclusive Global Licensing Deal with Saniona for SAN2355
Thursday, August 21, 2025Jazz Pharmaceuticals plchas entered into a global licensing agreement with Saniona to secure exclusive worldwide rights to develop and commercialise SAN The compound currently in preclinical development
Madrigal Secures European Commission Approval for Rezdiffra™ to Treat MASH with Moderate to Advanced Liver Fibrosis
Wednesday, August 20, 2025Madrigal Pharmaceuticals Inchas received conditional marketing authorisation from the European Commission EC for Rezdiffra resmetirom indicated for adults with noncirrhotic metabolic dysfunctionassociated
Skyhawk Therapeutics Enters Strategic Collaboration with Merck to Develop RNA-Targeting Small Molecules for Neurological Disorders
Tuesday, August 19, 2025Skyhawk Therapeutics Inc a biotechnology company specialising in RNAtargeting small molecules has entered into a strategic research collaboration with Merck a global science and technology company
Opus Genetics Receives FDA Clearance for IND Application of Gene Therapy Candidate OPGx-BEST1
Tuesday, August 19, 2025Opus Genetics Nasdaq IRD a clinicalstage biopharmaceutical company focused on gene therapies for inherited retinal diseases IRDs and small molecule treatments for eye disorders has gained clearance from the US Food and Drug Administration
Tonix Pharmaceuticals gains FDA approval for Tonmya™ in the treatment of fibromyalgia
Saturday, August 16, 2025Tonix Pharmaceuticals Holding Corp has announced that the US Food and Drug Administration FDA has approved Tonmya cyclobenzaprine HCl sublingual tablets for the treatment of fibromyalgia in adults
Precigen gains full FDA approval for PAPZIMEOS, the first therapy for recurrent respiratory papillomatosis in adults
Saturday, August 16, 2025Precigen Inc has received full approval from the US Food and Drug Administration FDA for PAPZIMEOS zopapogene imadenovecdrba a novel immunotherapy for the treatment of adults with recurrent respiratory
BioCardia and CART-Tech Form Exclusive Partnership for Heart3D™ Fusion Imaging in Interventional Cardiology
Thursday, August 14, 2025BioCardia Inca global leader in cellular and cellderived therapeutics for cardiovascular and pulmonary conditions has entered into an exclusive development and commercialisation
Airway Therapeutics Gains EMA Approval for Study Plan of Zelpultide Alfa in Preventing Bronchopulmonary Dysplasia in Very Preterm Infants
Wednesday, August 13, 2025Airway Therapeutics Inc a clinicalstage biopharmaceutical company developing biologic therapies for respiratory inflammatory and infectious diseases has received approval from the European Medicines Agencys EMA
Bayer and Kumquat Biosciences Sign Global Agreement to Develop KRAS G12D Inhibitor for Cancer Treatment
Wednesday, August 13, 2025Bayer has entered into an exclusive worldwide licence and collaboration with Kumquat Biosciences Inc a clinicalstage biotechnology company specialising in the KRAS pathway to develop and commercialise Kumquats KRAS GD inhibitor
